Articles from Biotech Financial Reports (May 1, 2006)

Title	Author	Type	Words
MGI PHARMA EXPECTS $78 MILLION TOTAL REVENUE FOR FIRST QTR.			485
NORTHFIELD LABS REPORTS 'O6 FISCAL 3RD QTR NET LOSS OF 6.4 MIL.			608
SIMULATIONS PLUS SETS RECORD FOR 2ND QTR REVENUES/EARNINGS.			830
VASOMEDICAL HAD NET LOSS OF $695,000 OR $0.01 PER COMMON SHARE.			714